Agencies ready to rock for charity

Share this article:
Last year's winners: "Licensed to Heal" from CDMiConnect
Last year's winners: "Licensed to Heal" from CDMiConnect

It's that time of year when, for one gloriously amped evening, healthcare agencies switch focus from brands to bands and strut their musical talents on the big stage. 

Pharmapalooza, the industry's annual “battle of the bands” contest, returns to B.B. King Blues Club & Grill (237 West 42 Street, New York) on Wednesday, November 6th at 7pm.

As in previous years, all proceeds from the event, which is hosted by New York-based CDM Group, will benefit The Children's Hospital at Montefiore. Last year's event raised more than $100,000.

This year's line-up includes ensembles from AbelsonTaylor (“Hard to Swallow”), Grey Healthcare Group (“Pharma's Daughter”), Publicis Kaplan Thaler (“Hot Flash”), CDMi (“Urge to Merge”) and CDM Princeton (“The Jughandles”).

Bringing home the trophy last year was CDMiConnect collective "Licensed to Heal" with a rousing tribute set to recently deceased Beastie Boys' legend, Adam Yauch.

A limited number of general admission tickets and VIP tables for Pharmapalooza 6 are still available here. If you are unable to attend but would like to make a donation, please contact pharmapalooza@cdmny.com.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...